§1125.14. Use of registry data

            A. The secretary of the department shall facilitate access to data in the registry as provided for in rule.

            B. Notwithstanding any other provision of law to the contrary, the department or its agent may access medical and vital records in the custody of physicians, hospitals, clinics, other healthcare providers, and the office of public health in order that it may conduct sickle cell disease studies. The data contained in the registry as well as all such medical and vital records obtained by the department or its agent in accordance with the provisions of this Subsection, as well as the results of any sickle cell disease study, shall be confidential and shall not be available for subpoena, nor shall such information be disclosed, discoverable, or compelled to be produced in any civil, criminal, administrative, or other proceeding nor shall such records be deemed admissible as evidence in any civil, criminal, administrative, or other tribunal or court for any reason. Nothing in this Subsection shall prohibit the publishing by the department of statistical compilations relating to sickle cell disease which do not identify individual cases or individual physicians, hospitals, clinics, or other healthcare providers.

            Acts 2022, No. 647, §2.